BEN
33
-5
CMA
50
-2
FDX
30
-9
AES
43
5
HSIC
45
8
EQT
30
-9
TSCO
45
2
HAL
50
3
AA
43
2
HCA
50
2
NKE
28
-2
EMC
62
6
CFG
52
-2
PYPL
41
2
UHS
56
4
SBUX
36
-3
GWW
64
-3
COP
54
4
TXN
46
-2
CAH
44
-6
BEN
33
-5
CMA
50
-2
FDX
30
-9
AES
43
5
HSIC
45
8
EQT
30
-9
TSCO
45
2
HAL
50
3
AA
43
2
HCA
50
2
NKE
28
-2
EMC
62
6
CFG
52
-2
PYPL
41
2
UHS
56
4
SBUX
36
-3
GWW
64
-3
COP
54
4
TXN
46
-2
CAH
44
-6
Financhill
Back

Arbutus Biopharma Vs. FibroGen Industry Stock Comparison

Buy
51

ABUS
Arbutus Biopharma

Last Price:
3.87
Seasonality Move:
20.32%
Sell
41

FGEN
FibroGen

Last Price:
0.32
Seasonality Move:
45.73%
Buy
51
Arbutus Biopharma (ABUS) is a Buy

Is Arbutus Biopharma a Buy, Sell or Hold?

  • The current Arbutus Biopharma [ABUS] share price is $3.86. The Score for ABUS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • ABUS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
FibroGen (FGEN) is a Sell

Is FibroGen a Buy, Sell or Hold?

  • The current FibroGen [FGEN] share price is $0.32. The Score for FGEN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • FGEN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ABUS Stock Price Chart

What is Arbutus Biopharma's stock price today?

  • The Arbutus Biopharma share price today is $3.86
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing selling pressure, which indicates risk of future bearish movement.

FGEN Stock Price Chart

What is FibroGen's stock price today?

  • The FibroGen share price today is $0.32
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FGEN is experiencing selling pressure, which indicates risk of future bearish movement.

ABUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 43.93 Sell
Chaikin Money Flow: -767949 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.81 - 4.07) Sell
Bollinger Bands (100): (3.39 - 4.15) Buy

FGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 42.59 Sell
Chaikin Money Flow: -131340 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.32 - 0.38) Sell
Bollinger Bands (100): (0.28 - 0.92) Sell

ABUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.96 Sell
20-day SMA: 3.96 Sell
50-day SMA: 4.03 Sell
200-day SMA: 3.29 Buy
8-day EMA: 3.95 Sell
20-day EMA: 3.97 Sell
50-day EMA: 3.94 Sell
200-day EMA: 3.4 Buy

FGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.31 Buy
20-day SMA: 0.33 Sell
50-day SMA: 0.37 Sell
200-day SMA: 1.1 Sell
8-day EMA: 0.32 Buy
20-day EMA: 0.34 Sell
50-day EMA: 0.41 Sell
200-day EMA: 1.35 Sell

Arbutus Biopharma Earnings Growth & ABUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.

FibroGen Earnings Growth & FGEN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and an increase next year of $0.65 per share.

Arbutus Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

FibroGen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):